超越数字:从地理与性别视角深入审视喀麦隆第五次全国COVID-19疫苗接种运动
喀麦隆截至2022年11月仅4.5%人口接种基础免疫系列。本研究对第五次大规模接种运动的DHIS2数据做二次分析,该运动接种2 019 118剂,较第一轮增加46倍,覆盖率达总人口10.1%,但萨赫勒三区域男性接种 odds 高于女性,合并症人群全国覆盖率仅14%,报告不良反应为每1000剂2例。
要点
- 第五次运动接种2 019 118剂,较第一轮增加46倍,覆盖总人口10.1%。
- 萨赫勒三区域男性接种 odds 高于女性,合并症人群全国覆盖率仅14%。
- 强政治承诺、国际支持、协作、规划、督导与需求生成是成功因素。
核心结论
- 第五次COVID-19疫苗接种运动凭借强政治承诺成为喀麦隆迄今最成功的一轮,但部分区域仍存在性别差异,需保持势头、确保萨赫勒区域公平可及并覆盖高危人群的基础免疫与加强针。
研究设计与样本
- 对第五次COVID-19大规模接种运动期间DHIS2数据进行的二次分析,采用描述性统计与卡方检验评估各地区及性别覆盖率差异。
主要发现
- 运动接种2 019 118剂,较第一轮接种人数增加46倍,覆盖率达总人口10.1%。
- 萨赫勒三区域男性接种 odds 高于女性。
- 合并症人群全国覆盖率仅14%,远北与东部区域覆盖率最低。
- Janssen为最常用疫苗,报告不良反应总数为每1000剂2例。
关键数值与推荐
- 截至2022年11月,仅4.5%人口接种基础免疫系列。
- 运动目标为接种至少3 000 000剂。
- 实际接种2 019 118剂,覆盖率达总人口10.1%。
临床怎么用
- 作者认为应继续保持已建立的势头,确保萨赫勒区域公平可及,并以基础免疫和加强针覆盖高危人群。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cameroon has been struggling with low Covid-19 vaccination coverage, with only 4.5 % of the population receiving the primary series as of November 2022. The COVID-19 Vaccine Delivery Partnership (CoVDP) conducted a high-level mission to Cameroon to assess progress and advocate for actions to address bottlenecks. The objective of the mission was to administer at least 3,000,000 doses of vaccines during the 5th Mass vaccination campaign. This study examines the factors contributing to the success of the campaign and uses a geographical and gender lens to assess the results. METHODS: The study is a secondary analysis of data from the DHIS2 collected during the 5th mass vaccination campaign for Covid-19. Descriptive statistics were used to assess coverages per location and gender expressed in OR. sccess factors, and chi-squared tests were used to assess differences in vaccine distribution across regions and by gender. RESULTS: This 5th vaccination campaign benefitted from a strong political commitment facilitated by CoVDP's mission, international support, collaboration, planning, supervision, and demand generation. The campaign recorded 2 019 118 administered vaccine doses, a staggering 46-fold increase in vaccinated individuals relative to the first round, with vaccination coverage reaching 10.1 % of the general population. However, the study reveals regional and gender disparities in vaccination coverage. Men had higher odds of being vaccinated than women in the three Sahel regions. Among individuals with comorbidities, the national coverage rate was only 14 %, and the Far North and East regions exhibited the lowest coverage rates. Janssen was the most used vaccine, and the total AEFI cases reported were 2 per 1000 vaccine doses. CONCLUSION: The 5th COVID-19 vaccination campaign in Cameroon saw a strong political commitment and was the most successful so far. Despite the gains, there was gender disparity in coverage in some regions. It is important to continue the established momentum, ensure equitable access in the Sahel regions, and reach high-priority groups with primary series and booster doses.
引用
- Amani A, Njoh AA, Atuhebwe P, et al. Beyond the numbers: An in-depth look at Cameroon's fifth national COVID-19 vaccination campaign through geographical and gender lenses. Vaccine. 2023. PMID: 37524630. doi:10.1016/j.vaccine.2023.07.062
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。